Gene · 6283
Papers3,572
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,572
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Amlexanox reduces new-onset atrial fibrillation risk in sepsis by downregulating S100A12: a Mendelian randomization study. | Front Cardiovasc Med | 2024 | 39444551 | PubTator, text mining | PubMed |
| Serum Soluble Receptors for Advanced Glycation End-Products May Predict Mortality in Microscopic Polyangiitis and Granulomatosis with Polyangiitis. | Yonsei Med J | 2024 | 39439169 | PubTator, text mining | PubMed |
| The levels of amino acid metabolites in serum induce the pathogenesis of atopic dermatitis by mediating the inflammatory protein S100A12. | Sci Rep | 2024 | 39379513 | PubTator, text mining | PubMed |
| Significance of pyroptosis-related genes in the diagnosis and classification of diabetic kidney disease. | Ren Fail | 2024 | 39378104 | PubTator, text mining | PubMed |
| Altered immune cell in human severe acute pancreatitis revealed by single-cell RNA sequencing. | Front Immunol | 2024 | 39372399 | PubTator, text mining | PubMed |
| Recent advances in proteomic analysis to study carotid artery plaques. | JVS Vasc Sci | 2024 | 39351586 | PubTator, text mining | PubMed |
| Construction of a NETosis-related gene signature for predicting the prognostic status of sepsis patients. | Heliyon | 2024 | 39281624 | PubTator, text mining | PubMed |
| Metabolite of esculetin plays an important role in cytotoxic effects induced by chloroquine on porcine immature Sertoli cells. | Toxicol In Vitro | 2024 | 39278285 | PubTator, text mining | PubMed |
| Effects of S100A12 reduction on H2O2-induced injury of human vascular smooth muscle cells (HVSMCs) [Retraction]. | Int J Clin Exp Pathol | 2024 | 39262438 | PubTator, text mining | PubMed |
| Evaluation of inflammatory biomarkers and their association with anti-SARS-CoV-2 antibody titers in healthcare workers vaccinated with BNT162B2. | Front Immunol | 2024 | 39247198 | PubTator, text mining | PubMed |
| Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohort. | RMD Open | 2024 | 39242113 | PubTator, text mining | PubMed |
| RNAseqCovarImpute: a multiple imputation procedure that outperforms complete case and single imputation differential expression analysis. | Genome Biol | 2024 | 39227979 | PubTator, text mining | PubMed |
| Cross-tissue organization of myeloid cells in scleroderma and related fibrotic diseases. | Curr Opin Rheumatol | 2024 | 39171604 | PubTator, text mining | PubMed |
| Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis. | Arthritis Care Res (Hoboken) | 2024 | 39135452 | PubTator, text mining | PubMed |
| Dissecting the mediating role of cytokines in the interaction between immune traits and sepsis: insights from comprehensive mendelian randomization. | Front Immunol | 2024 | 39076981 | PubTator, text mining | PubMed |
| High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19. | Viruses | 2024 | 39066246 | PubTator, text mining | PubMed |
| Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers. | Biomedicines | 2024 | 39062093 | PubTator, text mining | PubMed |
| Key extracellular proteins and TF-miRNA co-regulatory network in diabetic foot ulcer: Bioinformatics and experimental insights. | PLoS One | 2024 | 39037979 | PubTator, text mining | PubMed |
| Causal association between circulating inflammatory markers and sciatica development: a Mendelian randomization study. | Front Neurol | 2024 | 39015317 | PubTator, text mining | PubMed |
| Unraveling shared molecular signatures and potential therapeutic targets linking psoriasis and acute myocardial infarction. | Sci Rep | 2024 | 39014096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6283/papers?page=13